未登录

P

Philippe Soubeyran

institut national de la santé et de la recherche médicale (inserm)

H指数:29

被引数:3,013

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

E-Cadherin Is a Structuring Component of Invadopodia in Pancreatic Cancer

E-Cadherin 是胰腺癌侵袭小体的一种结构成分。

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

IF4.2

2025-05-140

OA

Targeting NUPR1-dependent stress granules formation to induce synthetic lethality in KrasG12D-driven tumors

EMBO MOLECULAR MEDICINE

IF8.3

2024-02-151

OAAI

The secreted tyrosine phosphatase PtpA promotes Staphylococcus aureus survival in RAW 264.7 macrophages through decrease of the SUMOylation host response

MICROBIOLOGY SPECTRUM

IF3.8

2023-12-122

OAAI

Targeting stress granule formation as a synthetic lethality strategy for kras-induced pancreatic cancer initiation

ANNALS OF ONCOLOGY

IF65.4

2023-10-010

PRE

Pancreatic ductal adenocarcinoma ubiquitination profiling reveals specific prognostic and theranostic markers

IF10.8

2023-06-015

OAAI

NUPR1 protects against hyperPARylation-dependent cell death

COMMUNICATIONS BIOLOGY

IF5.1

2022-07-2212

OAAI

TNF-α induces endothelial-mesenchymal transition promoting stromal development of pancreatic adenocarcinoma

CELL DEATH & DISEASE

IF9.6

2021-06-2549

OAAI

Metabolomic profiling of pancreatic adenocarcinoma reveals key features driving clinical outcome and drug resistance

胰腺腺癌的代谢组学分析揭示了驱动临床结果和耐药性的关键特征

IF10.8

2021-04-0129

OAAI

NUPR1 interacts with eIF2α and is required for resolution of the ER stress response in pancreatic tissue

NUPR1与eIF2α 相互作用，并且是解决胰腺组织中ER应激反应所必需的

IF4.2

2021-01-259

OAAI

ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents

IF6.1

2020-09-1731

OA

MiR-93 is related to poor prognosis in pancreatic cancer and promotes tumor progression by targeting microtubule dynamics

IF6.4

2020-05-0418

OAAI

Upcoming Revolutionary Paths in Preclinical Modeling of Pancreatic Adenocarcinoma

FRONTIERS IN ONCOLOGY

IF3.3

2020-01-2224

OAAI

Targeting the Stress-Induced Protein NUPR1 to Treat Pancreatic Adenocarcinoma

IF5.2

2019-11-1734

OAAI

PML hyposumoylation is responsible for the resistance of pancreatic cancer

PML低sumo化是胰腺癌耐药的原因

IF4.2

2019-09-1613

OAAI

Ligand-based design identifies a potent NUPR1 inhibitor exerting anticancer activity via necroptosis

基于配体的设计确定了一种通过坏死性凋亡发挥抗癌活性的有效NUPR1抑制剂

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2019-05-1374

OA

Inactivation of NUPR1 promotes cell death by coupling ER-stress responses with necrosis

SCIENTIFIC REPORTS

IF3.9

2018-11-1952

OAAI

Intrinsically disordered chromatin protein NUPR1 binds to the C-terminal region of Polycomb RING1B

本质上无序的染色质蛋白NUPR1与Polycomb RING1B的C末端区域结合

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2017-07-1845

OAAI

Usage of epoetin alfa biosimilars in the management of chemotherapy-induced anemia in patients with breast cancer: A subanalysis of the ORHEO study

CANCER RESEARCH

IF16.6

2016-02-150

PRE

ArgBP2 and the SoHo family of adapter proteins in oncogenic diseases

CELL ADHESION & MIGRATION

IF3.5

2014-10-2739

OAAI

Identification of New Mechanisms of Cellular Response to Chemotherapy by Tracking Changes in Post-Translational Modifications by Ubiquitin and Ubiquitin-Like Proteins

JOURNAL OF PROTEOME RESEARCH

IF3.6

2014-04-0230

PREAI